Altogether, these findings suggest that NAG-1/GDF15 could be an effective molecular target for colorectal cancer treatment, as it simultaneously impacts multiple signaling pathways, potentially generating synergistic anticancer effects. The gene discussed is GDF15; the disease is colorectal cancer.